NCT05602402View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of CAEP-01 on Eye Strain in Children With Heavy Screen Use

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 11, 2022

Primary Completion Date

April 24, 2023

Study Completion Date

April 24, 2023

Conditions
Vision Disorders
Interventions
OTHER

CAEP-01

Dose: 1 capsule Route: orally for 84 ± 3 days Regimen: one capsule before breakfast (preferably with milk/butter/ghee)

OTHER

Placebo

Dose: 1 capsule Route: orally for 84 ± 3 days Regimen: one capsule before breakfast (preferably with milk/butter/ghee)

Trial Locations (3)

302017

Jaipur National University Institute for Medical Sciences & Research Centre, Jaipur

390021

Aman Hospital and Research Center, Ahmedabad

400601

Wavikar Eye Institute, Thāne

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY